SJM dharna in Delhi against Novartis
June 8, 2023
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
    • Podcast
SUBSCRIBE
No Result
View All Result
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
    • Podcast
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • G20
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • My States
  • Vocal4Local
  • Subscribe
Home General

SJM dharna in Delhi against Novartis

Archive Manager by WEB DESK
Jul 15, 2012, 12:00 am IST
in General
Share on FacebookShare on TwitterTelegramEmail

Swadeshi Jagran Manch activists staged a dharna at Jantar Mantar in New Delhi on July 10 to protest against Norvatis pharmaceutical company. The demonstrators demanded the Government of India not to award Novartis a patent for its anti-cancer drug, Glivec. Similar demonstrations were organised at many places across the globe including Cape Town in South Africa the same day. Many organisations all around the globe are pursuing Indian government not to succumb before the Novratis.

The SJM urged the government to depute Attorney General to appear and argue in this case, so that this case is handled effectively. The workers also demanded an immediate ban on the acquisition of Indian pharmaceutical companies by foreign companies. At the same time the Swadeshi Jagran Manch warned the Novratis to withdraw its case in view of its likely impact on the public health in the country.

It is to be noted that a legal battle is on between Swiss pharmaceutical company Novartis and Government of India in the Supreme Court. Final hearing and arguments of this case began on July 10. Many companies in India manufacture a drug named Glivec. This drug is effective for blood cancer. The price at which Novratis sells this drug is Rs 1,20,000 per month (four tablets per day), whereas the Indian companies manufacturing this drug sells the same at rupees 10,000 per month. If monopolised, this drug would be unaffordable to most of the users (blood cancer patients) and will cause death for them.     (FOC)

ShareTweetSendShareSend
Previous News

Exploring climate patterns in Asia Pacific

Next News

Protect Nature to Protect Humans

Related News

Maharashtra: Violence in Kolhapur over WhatsApp messages glorifying Aurangzeb and Tipu Sultan

Maharashtra: Violence in Kolhapur over WhatsApp messages glorifying Aurangzeb and Tipu Sultan

Wrestlers halt protest till June 15 after meeting Anurag Thakur; WFI Elections to be held by June 30

Wrestlers halt protest till June 15 after meeting Anurag Thakur; WFI Elections to be held by June 30

9 Years of Modi Govt: Towards the Goal of Affordable & Accessible Healthcare

9 Years of Modi Govt: Towards the Goal of Affordable & Accessible Healthcare

Auto Draft

Over 100 eminent citizens support inclusion of Savarkar and removal of Iqbal from DU’s political science syllabus

Loka Kerala Sabha: Controversy over CM Vijayan New York event, Oppn claims up to Rs 85 lakh charge to sit close to CM

Loka Kerala Sabha: Controversy over CM Vijayan New York event, Oppn claims up to Rs 85 lakh charge to sit close to CM

Meeting of Opposition leaders to be held in Patna on June 23: JDU president Lalan Singh

Meeting of Opposition leaders to be held in Patna on June 23: JDU president Lalan Singh

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Maharashtra: Violence in Kolhapur over WhatsApp messages glorifying Aurangzeb and Tipu Sultan

Maharashtra: Violence in Kolhapur over WhatsApp messages glorifying Aurangzeb and Tipu Sultan

Wrestlers halt protest till June 15 after meeting Anurag Thakur; WFI Elections to be held by June 30

Wrestlers halt protest till June 15 after meeting Anurag Thakur; WFI Elections to be held by June 30

9 Years of Modi Govt: Towards the Goal of Affordable & Accessible Healthcare

9 Years of Modi Govt: Towards the Goal of Affordable & Accessible Healthcare

Auto Draft

Over 100 eminent citizens support inclusion of Savarkar and removal of Iqbal from DU’s political science syllabus

Loka Kerala Sabha: Controversy over CM Vijayan New York event, Oppn claims up to Rs 85 lakh charge to sit close to CM

Loka Kerala Sabha: Controversy over CM Vijayan New York event, Oppn claims up to Rs 85 lakh charge to sit close to CM

Meeting of Opposition leaders to be held in Patna on June 23: JDU president Lalan Singh

Meeting of Opposition leaders to be held in Patna on June 23: JDU president Lalan Singh

“Degree of trust, confidence that India, US have was not present a decade ago: Kurt Campbell

“Degree of trust, confidence that India, US have was not present a decade ago: Kurt Campbell

“Serbia emerged as film destination for Indian filmmakers”: President Droupadi Murmu

“Serbia emerged as film destination for Indian filmmakers”: President Droupadi Murmu

Education: New Horizons for Hindu Studies

Education: New Horizons for Hindu Studies

Narendra Modi, Google, e-Conomy report

Google’s report says India’s internet economy to reach USD 1 trillion by 2030

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • My States
  • Vocal4Local
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Podcast
  • Subscribe
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Refund and Cancellation

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies